New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- Childhood cancer survivor graduates, writes new chapteron September 7, 2019 at 5:01 pm
Major cancer organizations label September as Childhood Cancer Awareness Month. Prada recently noted that Aug. 28 marked 16 years since her first diagnosis. Prada said she hopes her story sheds light ...
- Lung Ambition Alliance unveils new initiatives to address lung cancer survival at the World Conference on Lung Canceron September 7, 2019 at 5:01 pm
the Global Lung Cancer Coalition (GLCC) and AstraZeneca – will explore and overcome barriers to screening and early diagnosis, the development of innovative medicine and quality care, and pursue an ...
- Alexandra Daddario & Dan Reynolds Help Raise Millions for Pediatric Cancer Charityon September 7, 2019 at 1:25 pm
The mission of The Tyler Robinson Foundation is to strengthen families financially and emotionally as they cope with the tragedy of a pediatric cancer diagnosis by offsetting out-of-pocket life ...
- Tobacco cessation after cancer diagnosis: Declaration from the IASLCon September 7, 2019 at 10:07 am
The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer ...
- Head and Neck Cancer Diagnostics Market Advanced Technologies & Growth Opportunitieson September 7, 2019 at 6:00 am
Sep 07, 2019 (HTF Market Intelligence via COMTEX) -- AMA recently published a detailed study of over 180+ pages in its repository on 'Head and Neck Cancer Diagnostics' market covering interesting ...
- Researchers to create quick, low-cost cancer diagnosticon September 6, 2019 at 9:07 pm
Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of ...
- How Dallas punk icon Barry Kooda found comfort on Facebook after wife's cancer diagnosis and deathon September 6, 2019 at 12:10 pm
Laura Huebner never went to the doctor. Mostly, because she never got sick. But also, because she could not afford health insurance. The only reason she went to the clinic on Nov. 1, 2017, was because ...
- Non-Invasive Cancer Diagnostics Market Size, Growth, Analysis, Outlook by 2019 – Trends, Opportunities and Forecast to 2023on September 6, 2019 at 6:45 am
Sep 06, 2019 (AmericaNewsHour) -- The Non-Invasive Cancer Diagnostics market report, added by Market Study Report, LLC, descriptively covers the present & future growth trends, in addition to ...
- Kamala Harris tears up as she recalls her mother's cancer diagnosison September 5, 2019 at 11:20 pm
Democratic presidential candidate Kamala Harris recalls the moment her mother was diagnosed with cancer in video of an emotional exchange released Thursday. The first voice you hear on the video clip ...
via Bing News